Related Experiment Video
Updated: Aug 9, 2026
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Analysis of gene expression profiles in melanoma cells with acquired resistance against antineoplastic drugs
Balazs Györffy1, Violeta Serra, Verena Materna
1Institute of Pathology, Charité Campus Mitte, Universitätsmedizin Berlin, Berlin, Germany.
Abstract:
Resistance to various antineoplastic agents is common in the clinical management of malignant melanoma. The biological mechanisms conferring these different drug-resistant phenotypes are still unclear. To identify potential factors mediating drug resistance to melanoma cells, the mRNA expression profiles of the parental drug-sensitive human melanoma cell line MeWo and four derived drug-resistant sublines with acquired resistance against four commonly used drugs for melanoma treatment (cisplatin, etoposide, fotemustine and vindesine) were analysed. We investigated cDNA arrays with 43,000 cDNA clones ( approximately 30,000 unique genes) to study the expression patterns of these cell lines. We were able to simultaneously extract new candidate genes associated with drug resistance in malignant melanoma and to correlate the present findings with previously described resistance-associated genes. Using hierarchical clustering and analysing the overlap of genes with altered expression, we detected similarities between the expression signatures related to cisplatin and fotemustine resistance. The resistance against vindesine required a minimal set of changes in gene expression relative to the parental MeWo cell line. Our study provides new data that may be used to obtain further insight into the resistance characteristics of malignant melanoma.
Insights
This study analyzed gene expression in melanoma cells resistant to common cancer drugs. It identified potential genes contributing to drug resistance, offering insights into treatment challenges.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Malignant melanoma often develops resistance to antineoplastic agents, complicating treatment.
- The underlying biological mechanisms of drug resistance in melanoma are not fully understood.
Purpose of the Study:
- To identify novel genes and pathways associated with acquired drug resistance in human melanoma cells.
- To compare gene expression profiles of drug-sensitive and drug-resistant melanoma cell lines.
Main Methods:
- Analysis of mRNA expression profiles using cDNA arrays (43,000 cDNA clones, ~30,000 unique genes).
- Comparison of gene expression patterns between a parental drug-sensitive melanoma cell line (MeWo) and four derived drug-resistant sublines.
- Application of hierarchical clustering to identify similarities and differences in expression signatures.
Main Results:
- Identified candidate genes potentially mediating resistance to cisplatin, etoposide, fotemustine, and vindesine.
- Detected shared expression signatures between cisplatin and fotemustine resistance.
- Observed minimal gene expression changes associated with vindesine resistance compared to the parental cell line.
Conclusions:
- Provides new molecular data to enhance understanding of drug resistance mechanisms in malignant melanoma.
- Highlights potential gene targets for overcoming or predicting treatment resistance.
- Suggests distinct genetic pathways may underlie resistance to different antineoplastic agents.
